• IStent inject reduces IOP, medication burden at 36 months

    6 monthes ago - By Healio

    Patients implanted with two iStent injects after cataract surgery experienced reduced IOP and less reliance on medications after 36 months, according to a study.
    The prospective, nonrandomized, consecutive case series study included 81 eyes of patients with predominantly primary open-angle glaucoma or pseudoexfoliative glaucoma who underwent cataract surgery and were implanted with two iStent injects. Fifty-six percent of eyes were on three to four medications preoperatively, and one eye was medication-free. Approximately 32% of eyes had previously undergone glaucoma surgery. The
    Read more ...

     

  • Daily medication more cost-effective than monthly injections to prevent opioid relapse

    6 monthes ago - By Healio

    A daily dose of buprenorphine-naloxone is significantly less costly than monthly injections of extended-release naltrexone for treating opioid use disorder, according to findings published in Annals of Internal Medicine.
    Three medications - methadone, buprenorphine and naltrexone - are FDA approved for opioid use disorder, according to Sean M. Murphy, PhD, associate professor of research in health care policy and research at Weill Cornell Medical College, and colleagues wrote.
    However, “evidence regarding the economic value of these treatments, particularly evidence from
    Read more ...